U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA762360 ID: 762360

human gut metagenome

Intestinal Microbiota Signatures Predict Clinical Outcome and Immune-related Adverse Events in PD-1 Treated Melanoma Patients

The gut microbiome has been proposed to be a biomarker and a driver of response to immune checkpoint blockade therapy in cancer. More...
AccessionPRJNA762360
Data TypeRaw sequence reads
ScopeEnvironment
Organismhuman gut metagenome[Taxonomy ID: 408170]
unclassified sequences; metagenomes; organismal metagenomes; human gut metagenome
Grants
  • "Fecal Microbiota Transplant and PD-1 blockade in Melanoma" (Grant ID 5R01CA222203-04, National Institutes of Health)
SubmissionRegistration date: 10-Sep-2021
National Cancer Institute - NIH
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments174
Other datasets
BioSample94
SRA Data Details
ParameterValue
Data volume, Gbases891
Data volume, Tbytes0.28

Supplemental Content

Recent activity

Clear Turn Off Turn On
  • human gut metagenome
    human gut metagenome
    Intestinal Microbiota Signatures Predict Clinical Outcome and Immune-related Adverse Events in PD-1 Treated Melanoma Patients
    BioProject
  • PRJNA762360 (1)
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI
Support Center